Date
10 June 2021
De nieuwe pandemie: bacteriën die resistent zijn tegen antibiotica
Joris Kooiman for the Dutch channel NRC writes about the latest research from the Access to Medicine Foundation's AMR Benchmark.
Kooiman covers the latest report by the Access to Medicine Foundation, which examines how small- and medium-sized drug makers, which are essential in antibiotic development, are navigating a financially difficult market.
The author discusses the risk of a possible "silent pandemic" due to the overuse of antibiotics that can result in resistance to the medicines. He also refers to the "valley of death" that often impacts late-stage R&D efforts for small companies.
Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, is quoted in the article.